ArticleFrontiers in oncology2022

Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab.

Huohuan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.